Connecticut's last medical-only cannabis dispensary, Bluepoint Wellness, must relocate within Westport after local officials repeatedly denied permission for recreational sales. The move signals a potential end to exclusively medical marijuana outlets in the state unless zoning codes change. Opened in late 2019, Bluepoint stands apart from the 61 licensed stores statewide, 29 of which now sell both medical and recreational products.
Westport Zoning Blocks Recreational Shift
Westport amended its zoning code in 2021 to bar recreational cannabis businesses, pointing to traffic concerns after state legalization of adult-use marijuana. Bluepoint co-founder Nick Tamborrino told the Planning and Zoning Commission in 2023 that staff turn away local residents daily seeking recreational products. Frustrated by the impasse, the company opened Venu Flower Collective, a recreational store 50 miles away in Middletown.
Medical Patient Base Shrinks Amid Recreational Rise
Medical cannabis patients in Connecticut fell from nearly 49,000 to under 32,000 since recreational sales launched in 2023. Annual medical sales dropped $21 million in 2025, with transactions declining from 2.6 million in 2024 to 2.2 million the next year. Fine Fettle chief operating officer Ben Zachs noted the challenge of sustaining medical-only operations, as his company runs nine hybrid shops across the state.
Factors Driving Market Transition and Patient Exodus
State cannabis ombudsman Erin Gorman Kirk links the patient decline to high prices, inconsistent product quality, and limited variety compared to neighboring Massachusetts and Rhode Island. Bluepoint plans to keep its medical dispensary in Westport for 18 to 24 months before shifting to a hybrid model in an unidentified town. This trajectory underscores local control's power over state policy, pushing even dedicated medical providers toward full-market participation.
